OMOP Concept 1832649
40 ML obinutuzumab 25 MG/ML Injectable Solution [Gazyvaro] by Abacus Medicine
StandardDrugRxNorm ExtensionOMOP5157882Marketed Product
Maps from
1
Descendants
0
Valid from
1 Sept 2021
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to 40 ML obinutuzumab 25 MG/ML Injectable Solution [Gazyvaro] by Abacus Medicine via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| GGR | 4204228 | Gazyvaro (Abacus) inf. oploss. (conc.) i.v. [flac.] 1x 1g/40ml | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(21)Roll up to these when you need a wider cohort.
- 140 ML obinutuzumab 25 MG/ML Injectable Solution
- 140 ML obinutuzumab 25 MG/ML Injectable Solution [Gazyvaro]
- 1obinutuzumab 25 MG/ML Injectable Solution
- 1obinutuzumab 25 MG/ML Injectable Solution [Gazyvaro]
- 2obinutuzumab 25 MG/ML
- 2obinutuzumab 25 MG/ML [Gazyvaro]
- 2obinutuzumab Injectable Solution
- 2obinutuzumab Injectable Solution [Gazyvaro]
- 3obinutuzumab
- 3obinutuzumab; parenteral
- 4Anti-CD20 antibody
- 4CD20 (Clusters of Differentiation 20) inhibitors
- 5Antineoplastic monoclonal antibody
- 5Immunosuppressive monoclonal antibody
- 5MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- 6Antibody medication
- 6ANTINEOPLASTIC AGENTS
- 6Immunosuppressant
- 6Targeted therapeutic
- 7ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- 7Antineoplastics by class effect
Get this concept via the API
Resolve 40 ML obinutuzumab 25 MG/ML Injectable Solution [Gazyvaro] by Abacus Medicine - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/1832649?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card